Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sue-jean Lin currently holds 27,567 shares of Arcutis Biotherapeutics, Inc. (ARQT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sue-jean Lin has been a net seller of ARQT stock. They have purchased $0 and sold $898.5K worth of shares.
Sue-jean Lin's most recent insider trade was on Jun 15, 2026, when they sold 4,946 shares at $24.38 per share.
Sue-jean Lin serves as Executive at Arcutis Biotherapeutics, Inc. (ARQT). They have executed 11 insider transactions totaling $898.5K over their tenure at the company.
Sue-jean Lin holds the position of Executive at Arcutis Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Sue-jean Lin has shown a selling trading pattern, with $0 in total purchases and $898.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sue-jean Lin was on Nov 24, 2025, when they sold $777.9K worth of ARQT shares. This transaction involved 25,272 shares at $30.78 per share.
Sue-jean Lin currently owns 27,567 shares of Arcutis Biotherapeutics, Inc. (ARQT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sue-jean Lin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sue-jean Lin has 11 Form 4 filings on record as an insider at Arcutis Biotherapeutics, Inc..
Set alerts for Sue-jean Lin and 40,000+ other insiders.